Quipt Home Medical Corp (TSE:QIPT) has released an update.
Quipt Home Medical Corp announced a 10% revenue increase in Q2 2024 over the previous year, with adjusted EBITDA up by 14%, signaling robust financial health. Despite challenges such as the expiration of the Medicare 75/25 blended rate and adjustments in Medicare Advantage memberships, the company maintained strong recurring revenue, which constituted 79.6% of total revenue. The company also reported a net loss for the quarter but an improvement in cash flow from operations over the six-month period.
For further insights into TSE:QIPT stock, check out TipRanks’ Stock Analysis page.
